Alcon will be listed in the New York Stock Exchange and on the Swiss Market. On Friday, Novartis stated, Alcon – its eye care business which it spun-off, is expected to be listed at the New York Stock Exchange and on the Swiss Market on April 9. “Alcon obtained approval for listing on SIX Swiss…
The purchase will bolster its cancer fighting pipeline. Drug manufacturer Bristol-Myers Squibb disclosed it would be acquiring privately held IFM Therapeutics for $300 million. The acquisition, backed by Novartis, will boost its cancer portfolio, since it will be able to access IFM’s preclinical cancer programs. Incidentally, IFM investors are also eligible to additional contingent payments…
The new fund will provide funding to both public and private firms for products that have already reached mid-stage Phase II clinical development, providing them with a new source of growth capital. In a move that underscores the wide net Google has cast across industries, the search engine giant has sunk in $300 million in…
business-gurus.com 